公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 MBIOLOG DIAGNÓSTICOS LTDA取消

59 记录

产品持有公司班级有效性
IMUNOSCREEN SÍFILIS TOTAL DBS80047580230MBIOLOG DIAGNÓSTICOS LTDAIV15/06/2036
IMUNOSCREEN CMV IGG DBS80047580229MBIOLOG DIAGNÓSTICOS LTDAIV18/02/2036
IMUNOSCREEN TOXOPLASMOSE IGG DBS80047580228MBIOLOG DIAGNÓSTICOS LTDAIV14/07/2035
IMUNOSCREEN CMV IGM DBS80047580227MBIOLOG DIAGNÓSTICOS LTDAIV07/07/2035
IMUNOSCREEN RUBÉOLA IGM DBS80047580226MBIOLOG DIAGNÓSTICOS LTDAIII19/05/2035
IMUNOSCREEN NEO TSH DBS80047580224MBIOLOG DIAGNÓSTICOS LTDAIII28/04/2035
IMUNOSCREEN NEO IRT DBS80047580225MBIOLOG DIAGNÓSTICOS LTDAIII28/04/2035
IMUNOSCREEN CHAGAS DBS80047580223MBIOLOG DIAGNÓSTICOS LTDAIV04/11/2034
IMUNOSCREEN NEO 17-OHP DBS80047580220MBIOLOG DIAGNÓSTICOS LTDAIII14/02/2034
IMUNOSCREEN NEO PKU - SS80047580218MBIOLOG DIAGNÓSTICOS LTDAIII11/09/2033
IMUNOSCREEN TOXO IGM DBS80047580217MBIOLOG DIAGNÓSTICOS LTDAIV02/05/2033
IMUNOCROM MB SANGUE OCULTO80047580212MBIOLOG DIAGNÓSTICOS LTDAIII07/02/2032
Dímero D Turb Cepa80047580211MBIOLOG DIAGNÓSTICOS LTDAIII31/01/2032
ALLSERUM EIA COVID-19 AC TOTAIS80047580210MBIOLOG DIAGNÓSTICOS LTDAIII20/09/2031
IMUNOSCREEN ANTI-HBc SS80047580208MBIOLOG DIAGNÓSTICOS LTDAIV23/08/2031
ALLSERUM EIA SARS-COV-2 IGG80047580206MBIOLOG DIAGNÓSTICOS LTDAIII21/06/2031
ALLSERUM EIA SARS-COV-2 IGM80047580207MBIOLOG DIAGNÓSTICOS LTDAIII21/06/2031
ALLSERUM DENGUE IGG80047580203MBIOLOG DIAGNÓSTICOS LTDAIII08/02/2031
ALLSERUM EIA Covid-19 IgG Dried Blood Spot80047580202MBIOLOG DIAGNÓSTICOS LTDAIII22/06/2030
IMUNOCROM MB DENGUE NS180047580197MBIOLOG DIAGNÓSTICOS LTDAIII08/04/2029
IS HBSAG80047580193MBIOLOG DIAGNÓSTICOS LTDAIV27/11/2027
ALLSERUM ZIKA IGM80047580190MBIOLOG DIAGNÓSTICOS LTDAIV25/09/2027
ALLSERUM ZIKA IGG80047580191MBIOLOG DIAGNÓSTICOS LTDAIV25/09/2027
IMUNOCROM MB DENGUE IGG/IGM80047580189MBIOLOG DIAGNÓSTICOS LTDAIII29/05/2027
IMUNOCROM MB HIV 1/280047580188MBIOLOG DIAGNÓSTICOS LTDAIV08/05/2027

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家